|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$51,467.67 |
2.77% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$49,220.40 |
2.65% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$49,332.36 |
2.65% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$46,664.53 |
2.51% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$46,109.40 |
2.48% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$43,909.75 |
2.36% |
| Waters Corporation |
WAT |
941848103 |
123 |
$43,935.60 |
2.36% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$43,756.20 |
2.35% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$43,321.14 |
2.33% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$42,316.88 |
2.28% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$41,254.32 |
2.22% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$40,951.28 |
2.20% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$40,364.24 |
2.17% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,188.39 |
2.16% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$39,786.25 |
2.14% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$39,637.03 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$39,323.01 |
2.11% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$38,747.52 |
2.08% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$38,247.23 |
2.06% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$38,115.12 |
2.05% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,797.97 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$37,167.56 |
2.00% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$37,046.79 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$37,078.65 |
1.99% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$36,954.54 |
1.99% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$36,814.11 |
1.98% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$36,699.60 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$36,584.00 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,364.13 |
1.96% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$36,514.80 |
1.96% |
| Steris Plc |
STE |
G8473T100 |
177 |
$35,968.17 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$35,960.00 |
1.93% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$35,487.76 |
1.91% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$35,076.66 |
1.89% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,880.98 |
1.88% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$34,817.40 |
1.87% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$34,699.20 |
1.87% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$34,585.25 |
1.86% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,281.36 |
1.84% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$33,457.58 |
1.80% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$33,156.10 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$32,896.72 |
1.77% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,715.84 |
1.76% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$31,796.10 |
1.71% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$31,538.85 |
1.70% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$29,047.20 |
1.56% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$28,780.00 |
1.55% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$28,191.73 |
1.52% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$25,188.02 |
1.35% |
| US Dollar |
$USD |
|
10,493 |
$10,493.49 |
0.56% |
| Japanese Yen |
$JPY |
|
91,571 |
$566.72 |
0.03% |
| New Zealand Dollar |
$NZD |
|
679 |
$385.03 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|